Loading organizations...
§ Private Profile · Parsippany, NJ, USA
AI healthcare marketing, connecting life sciences brands with HCPs via programmatic advertising for personalized, privacy-compliant messaging.
Doceree is an AI-powered programmatic advertising platform for healthcare marketing based in Parsippany, New Jersey. The company provides an operating system that connects life sciences brands with healthcare professionals by analyzing clinical, behavioral, and contextual signals to deliver personalized, privacy-compliant messaging directly at the point of care. Monetizing through fees for ad delivery and AI-driven targeting services, the platform facilitates secure connections between more than 115 pharmaceutical companies and a network of over 2,000 premium medical publishers. Operating across the United States, Canada, the United Kingdom, Germany, and Italy, the organization recently expanded its technological offerings by launching a unified ad management platform specifically for healthcare publishers. Doceree has scaled its enterprise to support a global workforce of 175 employees, generating $42.7 million in revenue while securing $59.6 million in total venture funding to date.
Doceree has raised $74.6M across 4 funding rounds.
Doceree has raised $74.6M in total across 4 funding rounds.
Doceree has raised $74.6M in total across 4 funding rounds.
Doceree's investors include Prakash Parthasarathy, Alumni Ventures, Flourish Ventures, F-Prime Capital Partners, Trevor Wright, Eight Roads Ventures, Alkemi Growth Capital.
Doceree has raised $74.6M across 4 funding rounds. Most recently, it raised $13.6M Series B in June 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 28, 2024 | $13.6M Series B | — | — | Announced |
| Sep 1, 2023 | $49M Series B | Prakash Parthasarathy | Alumni Ventures, Flourish Ventures, F Prime Capital, Trevor Wright | Announced |
| Apr 1, 2022 | $11M Series A | Eight Roads Ventures | Alkemi Growth Capital, Alumni Ventures, Flourish Ventures, F Prime Capital, Trevor Wright | Announced |
| May 12, 2020 | $1M Seed | — | — | Announced |
# Doceree: AI-Powered Operating System for Healthcare Marketing
Doceree is an AI-powered operating system designed specifically for healthcare marketing, enabling pharmaceutical and life-sciences brands to engage healthcare professionals (HCPs) with contextually relevant, privacy-compliant messaging[1][3]. Founded in 2019 and headquartered in Parsippany, New Jersey, the company has built the largest global healthcare marketing platform, serving over 115 pharmaceutical brands, 30+ agencies, and connecting with 6 million+ verified HCPs[7].
The company solves a critical fragmentation problem in healthcare marketing: pharmaceutical brands struggle to deliver unified, contextually intelligent campaigns across disparate channels and workflows. Doceree addresses this by consolidating identity resolution, clinical content alignment, workflow-based triggers, conversational AI, and cross-channel orchestration into a single, purpose-built platform[2]. Rather than repurposing generic ad tech for healthcare, Doceree is healthcare-native, integrating directly into clinician workflows and EHR systems to deliver measurably superior outcomes[2].
Doceree was founded in 2019 and marked its five-year milestone in 2025 with a major product expansion[1]. The company emerged from recognizing a fundamental gap in healthcare marketing: the industry lacked a unified platform that could inject richer context into every HCP interaction while maintaining strict privacy compliance[3]. Rather than building point solutions, the founders envisioned a comprehensive operating system—analogous to how DOS revolutionized computing—that would become the foundational technology for the entire healthcare marketing sector[1].
The company's trajectory accelerated significantly, culminating in late 2025 with the launch of five interconnected AI-driven innovations at Fierce Pharma Week 2025, including RepTwin (an AI-powered digital twin of pharmaceutical sales representatives) and the unified Doceree Operating System itself[1]. This milestone was further validated when OpenAI recognized Doceree for crossing 10 billion tokens, underscoring the sophistication of its AI infrastructure[3].
Patented AI Architecture: Doceree's proprietary AI understands multiple layers of context—who the HCP is, what they're reading, when they make decisions, and how campaigns are orchestrated—enabling precision that generic tools cannot match[2][4].
Healthcare-Native Design: Unlike repurposed ad tech platforms, Doceree is purpose-built from the ground up for healthcare, with direct integrations into 150+ EHR, eRx, and telehealth platforms and access to 500+ endemic and point-of-care platforms[5].
Deterministic HCP Identification: The platform connects with 6 million+ verified HCPs through deterministic identification (not third-party cookies), guaranteeing compliant and accurate messaging without privacy compromises[5].
Unified Product Ecosystem: The operating system integrates eight core solutions—Point-of-Care Messaging, Premium Programmatic, RepTwin, DataIQ, Marketplace, co-pay.com, Spark, and admanager—into a single intelligent framework rather than forcing brands to stitch together disparate tools[3].
Real-Time Workflow Integration: The platform's "Triggers" technology delivers HIPAA-compliant messages driven by clinical data at the moment of truth, directly within HCP workflows[5].
Transparent Measurement: Doceree offers physician-level analytics, real-time dashboards, and the ability to track prescriptions back to media campaigns, providing granular reporting that streamlines analytical workflows[4].
Doceree is riding the convergence of three powerful trends: the AI revolution, healthcare's digital transformation, and the pharmaceutical industry's shift toward precision marketing. The timing is critical—healthcare systems globally are digitizing workflows (EHRs, eRx platforms, telehealth), creating new touchpoints for engagement, while simultaneously demanding stricter privacy compliance and measurable ROI[2][5].
The company influences the broader ecosystem by establishing a new category: the healthcare-native operating system. Rather than allowing healthcare marketing to remain fragmented across generic platforms, Doceree is demonstrating that purpose-built, context-aware AI can deliver superior outcomes while maintaining compliance[1][2]. This approach is reshaping how the industry thinks about technology infrastructure—moving from point solutions to integrated platforms.
The recognition from OpenAI signals that Doceree's AI sophistication has reached enterprise scale, validating its claim to be the only true operating system for healthcare marketing[3]. This positions the company as a potential standard-setter for how AI should be embedded into regulated industries.
Doceree is at an inflection point. Having established its core platform and achieved significant scale (115+ pharma brands, 6M+ HCPs), the company is now focused on deepening AI capabilities and expanding its ecosystem. The launch of RepTwin—an AI-powered digital twin of sales representatives—signals a shift toward conversational AI and autonomous engagement, potentially reducing the need for traditional sales infrastructure[1].
The company's future will likely be shaped by three factors: (1) continued AI advancement in understanding clinical context, (2) expansion into adjacent healthcare segments (payers, patients, healthcare systems), and (3) potential IPO or acquisition as the healthcare marketing technology market consolidates. The OpenAI recognition and five-year milestone suggest Doceree has moved beyond startup phase into market leadership, making it a bellwether for how AI will transform regulated industries.
What's particularly noteworthy is Doceree's bet that the future of healthcare marketing isn't about more data or more channels—it's about *smarter context*. If that thesis proves correct, the company could become as foundational to healthcare marketing as Salesforce became to CRM.